[First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D006016:Glycolates / Q000627:therapeutic use*; D006073:Gout / Q000188:drug therapy*; D006218:Halofenate / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D010919:Placebos; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood
D006016:Glycolates; D000960:Hypolipidemic Agents; D010919:Placebos; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol; D006218:Halofenate
Erste klinische Erfahrungen in der Behandlung von Hyperurikämie und Hyperlipidämie mit dem Clofibratderivat MK 185.